Archdale Drug Co Inc | |
11220 N Main St, High Point, North Carolina 27263 | |
(336) 434-2776 |
Name | Archdale Drug Co Inc |
---|---|
Organization Name | Archdale Drug Co Inc |
Location | 11220 N Main St, High Point, North Carolina 27263 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (336) 434-2776 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Medgenics, Inc., developer of the novel Biopump technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the U.S. Food and Drug Administration to proceed with a Phase IIb clinical trial of EPODURE for the treatment of anemia in patients undergoing renal dialysis.
A new study by researchers at Ohio University found that Vitamin D3 could prevent and restore damage caused by several cardiovascular diseases.
In his mind, Basil Hubbard can already picture a new world of therapeutic treatments for millions of patients just over the horizon. It's a future in which diseases like muscular dystrophy, cystic fibrosis and many others are treated permanently through the science of genome engineering.
Minority women and women in general aged 50-64 in Pennsylvania showed an increased proportion of early-stage breast cancer diagnosis since the implementation of the Affordable Care Act (ACA).
Hana Biosciences, Inc., a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the three and nine months ended September 30, 2010, and provided a corporate update.
› Verified 7 days ago
NPI Number | 1467559393 |
Organization Name | ARCHDALE DRUG CO INC |
Doing Business As | ARCHDALE DRUG CO INC |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 11220 N Main St, Archdale, NC 27263 |
Phone Number | 336-434-2776 |
News Archive
Medgenics, Inc., developer of the novel Biopump technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the U.S. Food and Drug Administration to proceed with a Phase IIb clinical trial of EPODURE for the treatment of anemia in patients undergoing renal dialysis.
A new study by researchers at Ohio University found that Vitamin D3 could prevent and restore damage caused by several cardiovascular diseases.
In his mind, Basil Hubbard can already picture a new world of therapeutic treatments for millions of patients just over the horizon. It's a future in which diseases like muscular dystrophy, cystic fibrosis and many others are treated permanently through the science of genome engineering.
Minority women and women in general aged 50-64 in Pennsylvania showed an increased proportion of early-stage breast cancer diagnosis since the implementation of the Affordable Care Act (ACA).
Hana Biosciences, Inc., a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the three and nine months ended September 30, 2010, and provided a corporate update.
› Verified 7 days ago
News Archive
Medgenics, Inc., developer of the novel Biopump technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the U.S. Food and Drug Administration to proceed with a Phase IIb clinical trial of EPODURE for the treatment of anemia in patients undergoing renal dialysis.
A new study by researchers at Ohio University found that Vitamin D3 could prevent and restore damage caused by several cardiovascular diseases.
In his mind, Basil Hubbard can already picture a new world of therapeutic treatments for millions of patients just over the horizon. It's a future in which diseases like muscular dystrophy, cystic fibrosis and many others are treated permanently through the science of genome engineering.
Minority women and women in general aged 50-64 in Pennsylvania showed an increased proportion of early-stage breast cancer diagnosis since the implementation of the Affordable Care Act (ACA).
Hana Biosciences, Inc., a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the three and nine months ended September 30, 2010, and provided a corporate update.
› Verified 7 days ago
Advanced Home Infusion Type: Medicare Supplier Location: 4001 Piedmont Pkwy, High Point, North Carolina 27265 Phone: (336) 878-8980 | |
Archdale Drug Co Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11220 N Main St, High Point, North Carolina 27263 Phone: (336) 434-2776 | |
Deep River Drug Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2401 Hickswood Rd, High Point, North Carolina 27265 Phone: (336) 454-3784 | |
Bio Tech Prothestics And Orthotics Type: Durable Medical Equipment & Medical Supplies Supplier Location: 721 N Elm St, High Point, North Carolina 27262 Phone: (336) 889-7661 | |
Carolina Pain Relief Center Pllc Type: Medicare Supplier Location: 4146 Mendenhall Oaks Pkwy, High Point, North Carolina 27265 Phone: (336) 740-9580 |